## Abstract Spleen cells from tumor‐immune rats incorporate thymidine when co‐cultured for 4 days with syngeneic cancer cells. Non‐adherent cells, recovered from a 7‐day mixed culture with cancer cells, had lost their capacity for incorporating thymidine when exposed again to the same tumor cells;
Proliferative response of T cells from tumor-immune chickens to carcinogen-induced fibrosarcoma cells
✍ Scribed by Pascale Quere; Vincent K. Tsiagbe; G. Jeanette Thorbecke
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- French
- Weight
- 571 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Immunity to carcinogen‐induced transplantable fibrosarcomas (CHCT‐NYU‐4, ‐97, ‐36 and ‐20) in SC chickens was studied by the ability of spleen cells from NYU‐4 or ‐97 immune chickens to proliferate in response to tumor cells in vitro. Spleen, but not peripheral blood cells, from NYU‐4 immune chickens proliferated significantly more vigorously to gamma‐irradiated NYU‐4 cells than did cells from normal chickens. The proliferative response was not much affected by addition of indomethacin. Spleen cells from NYU‐4‐immune agammaglobulinemic (Aγ) chickens exhibit the same ability to proliferate in presence of gamma‐irradiated NYU‐4 tumor cells. Analysis of the phenotype of the T‐cell component involved in proliferation showed that the proliferative response was significantly decreased by removal of CT4^+^ cells through indirect panning. Removal of CT8^+^ cells enhanced background proliferation without affecting the total thymidine incorporation in the presence of tumor cells. Immune spleen cells usually gave highest responses to the immunizing tumor, but also exhibited cross‐reactivity to cells from other individual tumors induced by the same carcinogen.
📜 SIMILAR VOLUMES
## Abstract Spleen cells, thoracic duct lymphocytes and adherent peritoneal exudate cells from mice immunized to syngeneic plasma cell tumors were capable of transferring specific protective immunity to these tumors. Pre‐treatment of these cells with anti‐Θ serum or anti‐lymphocyte serum, but not w
## Abstract Cells from reticulum‐cell sarcomas (RCS), tumors with a probable B‐cell origin in the SJL/J mouse strain, induced a high degree of proliferation in 6‐bearing syngeneic lymph‐node and thymus cells obtained from young non‐tumorous mice. Although of considerably lower magnitude, a prolifer